Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 …

…, S Bologna, O Fitoussi, G Lepeu, C Fruchart… - The Lancet …, 2011 - thelancet.com
… HIV, hepatitis B virus, and hepatitis C virus serology was done 4 weeks or less before
treatment. IADL consisted of a simple questionnaire that included the following items: ability to use …

Hypodiploidy is a major prognostic factor in multiple myeloma

…, C Brigaudeau, D Leroux, C Fruchart - Blood, The Journal …, 2001 - ashpublications.org
Conventional karyotypes performed before any treatment in 208 patients with multiple
myeloma were reviewed by the Groupe Français de Cytogénétique Hématologique. A total of …

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open …

…, C Fruchart, B Corront, J Gabarre, C Bonnet… - The Lancet, 2011 - thelancet.com
… Disease-free survival for the 315 patients who achieved complete or unconfirmed complete
response to treatment (C); the number of patients in these estimates is different from the …

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised …

…, M Hacini, C Fruchart, L Ysebaert, C Fermé… - The lancet …, 2013 - thelancet.com
… Additional inclusion criteria were a life expectancy of at least 3 months and negative serological
tests for HIV and hepatitis B and C virus in the past 4 weeks (except after vaccination for …

[HTML][HTML] Rituximab plus lenalidomide in advanced untreated follicular lymphoma

…, H Tilly, ML Palomba, C Fruchart… - … England Journal of …, 2018 - Mass Medical Soc
Background Rituximab plus chemotherapy has been shown to be effective in patients with
advanced-stage, previously untreated follicular lymphoma; nevertheless, most patients will …

Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung …

…, PZ Zimmet, JI Cleeman, KA Donato, JC Fruchart… - Circulation, 2009 - Am Heart Assoc
A cluster of risk factors for cardiovascular disease and type 2 diabetes mellitus, which occur
together more often than by chance alone, have become known as the metabolic syndrome. …

[PDF][PDF] Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide …

…, D Caillot, C Fruchart, AM Stoppa, C Gentil… - J Clin …, 2014 - researchgate.net
… Certain relationships marked with a “U” are those for which no compensation was received;
those relationships marked with a “C” were compensated. For a detailed description of the …

LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients

…, A Rossi, F Pezzella, C Fruchart, C Duval… - 1994 - ashpublications.org
We have recently shown that an evolutionary conserved gene LAZ3, encoding a zinc finger
protein, is disrupted and overexpressed in some B-cell lymphomas (mainly with a large cell …

Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases

NV Smadja, C Fruchart, F Isnard, C Louvet, JL Dutel… - Leukemia, 1998 - nature.com
We report the cytogenetic results obtained in 81 multiple mye-loma (MM) patients with abnormal
karyotypes. Most karyotypes were complex with numerical and structural abnormalities …

Mechanism of action of fibrates on lipid and lipoprotein metabolism

…, J Auwerx, K Schoonjans, E Leitersdorf, JC Fruchart - Circulation, 1998 - Am Heart Assoc
… , VLDL-C, and triglycerides and increase HDL-C in combined hyperlipidemia. The reduction
in total cholesterol is accounted for by the fall in both VLDL-C and LDL-C, 51 whereas the …